134 related articles for article (PubMed ID: 25292047)
1. A novel all-trans retinoid acid derivative N-(3-trifluoromethyl- phenyl)- retinamide inhibits lung adenocarcinoma A549 cell migration through down-regulating expression of myosin light chain kinase.
Fan TT; Cheng Y; Wang YF; Gui SY; Chen FH; Zhou Q; Wang Y
Asian Pac J Cancer Prev; 2014; 15(18):7687-92. PubMed ID: 25292047
[TBL] [Abstract][Full Text] [Related]
2. New insights into 4-amino-2-tri-fluoromethyl-phenyl ester inhibition of cell growth and migration in the A549 lung adenocarcinoma cell line.
Wang H; Gui SY; Chen FH; Zhou Q; Wang Y
Asian Pac J Cancer Prev; 2013; 14(12):7265-70. PubMed ID: 24460286
[TBL] [Abstract][Full Text] [Related]
3. A novel all-trans retinoid acid derivatives inhibits the migration of breast cancer cell lines MDA-MB-231 via myosin light chain kinase involving p38-MAPK pathway.
Wang B; Yan Y; Zhou J; Zhou Q; Gui S; Wang Y
Biomed Pharmacother; 2013 Jun; 67(5):357-62. PubMed ID: 23602051
[TBL] [Abstract][Full Text] [Related]
4. A novel all-trans retinoid acid derivative induces apoptosis in MDA-MB-231 breast cancer cells.
Wang B; Yan YW; Zhou Q; Gui SY; Chen FH; Wang Y
Asian Pac J Cancer Prev; 2014; 15(24):10819-24. PubMed ID: 25605183
[TBL] [Abstract][Full Text] [Related]
5. All-Trans Retinoic Acid Inhibits Human Colorectal Cancer Cells RKO Migration via Downregulating Myosin Light Chain Kinase Expression through MAPK Signaling Pathway.
Zuo L; Yang X; Lu M; Hu R; Zhu H; Zhang S; Zhou Q; Chen F; Gui S; Wang Y
Nutr Cancer; 2016 Oct; 68(7):1225-33. PubMed ID: 27564600
[TBL] [Abstract][Full Text] [Related]
6. 4-Amino-2-trifluoromethyl-phenyl retinate inhibits the migration of BGC-823 human gastric cancer cells by downregulating the phosphorylation level of MLC II.
Hu A; Yang Y; Zhang S; Zhou Q; Wei W; Wang Y
Oncol Rep; 2014 Oct; 32(4):1473-80. PubMed ID: 25051015
[TBL] [Abstract][Full Text] [Related]
7. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
8. Effects of novel all-trans retinoic acid retinamide derivatives on the proliferation and apoptosis of human lung adenocarcinoma cell line A549 cells.
Gui SY; Chen FH; Zhou Q; Wang Y
Yakugaku Zasshi; 2011; 131(10):1465-72. PubMed ID: 21963974
[TBL] [Abstract][Full Text] [Related]
9. Melatonin inhibits the Migration of Colon Cancer RKO cells by Down-regulating Myosin Light Chain Kinase Expression through Cross-talk with p38 MAPK.
Zou DB; Wei X; Hu RL; Yang XP; Zuo L; Zhang SM; Zhu HQ; Zhou Q; Gui SY; Wang Y
Asian Pac J Cancer Prev; 2015; 16(14):5835-42. PubMed ID: 26320459
[TBL] [Abstract][Full Text] [Related]
10. Myosin light chain kinase is a potential target for hypopharyngeal cancer treatment.
Cao F; Zhu L; Zhang J; Pongkorpsakol P; Kuo WT; Turner JR; Zhou Q; Wang Y; Chen F; Liu Y; Zuo L
Biomed Pharmacother; 2020 Nov; 131():110665. PubMed ID: 32920510
[TBL] [Abstract][Full Text] [Related]
11. Melatonin inhibits the migration of human lung adenocarcinoma A549 cell lines involving JNK/MAPK pathway.
Zhou Q; Gui S; Zhou Q; Wang Y
PLoS One; 2014; 9(7):e101132. PubMed ID: 24992189
[TBL] [Abstract][Full Text] [Related]
12. A novel retinoic acid analog, 4-amino-2-trifluoromethyl-phenyl retinate, inhibits gastric cancer cell growth.
Hu KW; Pan XH; Chen FH; Qin R; Wu LM; Zhu HG; Wu FR; Ge JF; Han WX; Yin CL; Li HJ
Int J Mol Med; 2014 Feb; 33(2):415-22. PubMed ID: 24317440
[TBL] [Abstract][Full Text] [Related]
13. 4-Amino-2-trifluoromethyl-phenyl retinate inhibits proliferation, invasion, and migration of breast cancer cells by independently regulating CRABP2 and FABP5.
Ju J; Wang N; Wang J; Wu F; Ge J; Chen F
Drug Des Devel Ther; 2018; 12():997-1008. PubMed ID: 29731607
[TBL] [Abstract][Full Text] [Related]
14. Fenretinide inhibits the proliferation and migration of human liver cancer HepG2 cells by downregulating the activation of myosin light chain kinase through the p38‑MAPK signaling pathway.
Zhang L; Huang D; Shao D; Liu H; Zhou Q; Gui S; Wei W; Wang Y
Oncol Rep; 2018 Jul; 40(1):518-526. PubMed ID: 29767236
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic priming of non-small cell lung cancer cell lines to the antiproliferative and differentiating effects of all-trans retinoic acid.
Greve G; Schiffmann I; Lübbert M
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2171-80. PubMed ID: 26008188
[TBL] [Abstract][Full Text] [Related]
16. Tomatidine inhibits invasion of human lung adenocarcinoma cell A549 by reducing matrix metalloproteinases expression.
Yan KH; Lee LM; Yan SH; Huang HC; Li CC; Lin HT; Chen PS
Chem Biol Interact; 2013 May; 203(3):580-7. PubMed ID: 23566884
[TBL] [Abstract][Full Text] [Related]
17. Combination of nadroparin with radiotherapy results in powerful synergistic antitumor effects in lung adenocarcinoma A549 cells.
Zhuang X; Qiao T; Xu G; Yuan S; Zhang Q; Chen X
Oncol Rep; 2016 Oct; 36(4):2200-6. PubMed ID: 27498922
[TBL] [Abstract][Full Text] [Related]
18. ROS play an important role in ATPR inducing differentiation and inhibiting proliferation of leukemia cells by regulating the PTEN/PI3K/AKT signaling pathway.
Feng Y; Hua X; Niu R; Du Y; Shi C; Zhou R; Chen FH
Biol Res; 2019 May; 52(1):26. PubMed ID: 31053167
[TBL] [Abstract][Full Text] [Related]
19. All-Trans Retinoic Acid Induces Proliferation, Survival, and Migration in A549 Lung Cancer Cells by Activating the ERK Signaling Pathway through a Transcription-Independent Mechanism.
Quintero Barceinas RS; García-Regalado A; Aréchaga-Ocampo E; Villegas-Sepúlveda N; González-De la Rosa CH
Biomed Res Int; 2015; 2015():404368. PubMed ID: 26557664
[TBL] [Abstract][Full Text] [Related]
20. A novel all-trans retinoic acid derivative inhibits proliferation and induces apoptosis of myelodysplastic syndromes cell line SKM-1 cells via up-regulating p53.
Du Y; Li LL; Chen H; Wang C; Qian XW; Feng YB; Zhang L; Chen FH
Int Immunopharmacol; 2018 Dec; 65():561-570. PubMed ID: 30415163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
